NHS Diabetes Prevention Programme is expanding in England

19

Jun 2017

NHS Diabetes Prevention Programme is the program in England, which connects existing elements of health care system focused on prevention of diabetes and additional element of behavioral intervention for nondiabetic hyperglycaemia into a comprehensive program aimed on prevention of diabetes type II.

The program is collectively developed by NHS England, Public Health England (PHE) and Diabetes UK. It is expected that within 3-5-year time the Program will cover entire England. The Program is funded by NHS England. This Program is aligned with existing Weight Management Services (WMS) in England (4-level of care system).

The NHS DPP provides a behavioural intervention for individuals with nondiabetic hyperglycaemia (defined as having an HbA1c of 42 – 47 mmol / 6.0 - 6.4% or fasting plasma glucose (FPG) of 5.5 – 6.9 mmol/l) and therefore high risk for progression to Type 2 diabetes. Those with normal blood glucose levels (HbA1c < 42 mmol / 47 mmol or FPG ≥ 7mmol/l) are not be eligible for the NHS DPP intervention.

The intervention consists of a series of predominantly group based sessions delivered in person across a period of at least 9 months. There are at least 13 sessions and 16 hours of contact time. Sessions last between 1 and 2 hours and cover topics geared towards the programme’s main goals of dietary improvements, increased physical activity and weight reduction.

The first Wave of the Program has included 27 areas covering 26 million people. About 50,000 people referred in Wave 1 and more than 18,000 have been on the programme at the end of April 2017.

Wave 2 areas will cover another 25% of the population, with an estimated 130,000 referrals and up to 50,000 additional places made available thanks to the expansion.

Read more about NHS Diabetes Prevention Programme here.

Read more about Wave 2 of the Programme here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

01

Mar 2022

On February 04, 2022, NHSX announced merging with NHS Digital into the new Transformation Directorate at NHS England. NHSX's mission will remain the same - to drive the digital transformation of the NHS and social care.

Read more

16

Feb 2022

On February 02, 2022, NHS England updated the 2021/22 National Genomic Test Directory for rare and inherited diseases, initially published in October 2021. No new codes were introduced. Amendments were made in 77 codes, including changing the test method, commissioning category, specialist group.

Read more

11

Feb 2022

A new multi-agency advisory service (MAAS) is currently under development by the National Institute of Health and Care Excellence (NICE). This new cross-regulatory service will be a “one-stop-shop” for support, information, and guidance on the regulation and evaluation of AI technologies. The launch of the new service is scheduled for summer 2022.

Read more